Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

    Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi
    01-10-2018
    https://doi.org/10.4081/dr.2018.7859
    2027
    PDF: 1069
    HTML: 68
  • Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

    Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek
    11-04-2025
    https://doi.org/10.4081/dr.2025.10124
    613
    PDF: 403
    HTML: 6
  • Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

    Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone
    29-07-2021
    https://doi.org/10.4081/dr.2021.8797
    3068
    PDF: 651
    HTML: 13
  • Certolizumab to treat hidradenitis suppurativa

    Asem Shadid, Saud Alobaida, Yousef Binamer
    27-10-2022
    https://doi.org/10.4081/dr.2022.9566
    1951
    PDF: 735
    HTML: 32
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    478
    PDF: 320
    HTML: 11
  • Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

    Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi
    21-02-2025
    https://doi.org/10.4081/dr.2025.10278
    465
    PDF: 303
    HTML: 17
  • Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

    Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
    01-07-2025
    https://doi.org/10.4081/dr.2025.10315
    566
    PDF: 282
    HTML: 20
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    749
    PDF: 412
    HTML: 29
  • A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

    Shinpei Miura, Kanako Tsunoda, Hiroo Amano
    05-06-2023
    https://doi.org/10.4081/dr.2023.9699
    748
    PDF: 452
    HTML: 20
  • Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

    Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami
    06-12-2024
    https://doi.org/10.4081/dr.2024.10171
    1730
    PDF: 459
    HTML: 39
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1084
    PDF: 571
    HTML: 82
  • Isotretinoin musculoskeletal side effects: a systematic review

    Rahaf R. Almutairi, Atheer G. Almutairi, Afnan F. Alhallafi, Norah A. Almudawi, Mohammed Abdulaziz AlSulaiman, Asem M. Shadid, Ruaa Alharithy
    12-04-2024
    https://doi.org/10.4081/dr.2024.9845
    5655
    PDF: 1113
    SUPPLEMENTARY: 365
    HTML: 463
  • Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

    Paolo Dapavo, Matteo Megna, Marina Talamonti
    09-08-2024
    https://doi.org/10.4081/dr.2024.9999
    1780
    PDF: 689
    HTML: 99
  • Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

    Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi
    29-12-2022
    https://doi.org/10.4081/dr.2023.9613
    1789
    PDF: 545
    HTML: 77
  • Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

    Mitchell Hanson, McKenzie E. Maloney, Louis Kuchnir
    08-02-2024
    https://doi.org/10.4081/dr.2024.9866
    1208
    PDF: 746
    HTML: 24
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1175
    PDF: 831
    HTML: 44
  • Secondary prevention of hidradenitis suppurativa

    Hjalmar Kurzen, Marina Kurzen
    25-10-2019
    https://doi.org/10.4081/dr.2019.8243
    2861
    PDF: 1220
    HTML: 28
  • Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

    Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9091
    2638
    PDF: 637
    HTML: 10
  • Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

    Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini
    30-07-2025
    https://doi.org/10.4081/dr.2025.10379
    444
    PDF: 309
    HTML: 3
  • Treatment modalities of necrobiosis lipoidica: a concise systematic review

    Amir Feily, Shadi Mehraban
    08-06-2015
    https://doi.org/10.4081/dr.2015.5749
    2918
    PDF: 1903
    Suppl. Table: 445
    HTML: 497
  • Treatment satisfaction among patients with psoriasis in Saudi Arabia

    Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi
    15-04-2024
    https://doi.org/10.4081/dr.2024.9967
    1080
    PDF: 575
    HTML: 35
  • Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

    Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani
    04-02-2025
    https://doi.org/10.4081/dr.2025.10232
    527
    PDF: 335
    HTML: 15
  • Hidradenitis suppurativa: state-of-the-art review and update

    Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola
    27-08-2025
    https://doi.org/10.4081/dr.2025.10328
    860
    PDF: 623
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1100
    PDF: 728
    HTML: 64
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

    Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino
    25-06-2020
    https://doi.org/10.4081/dr.2020.8642
    1379
    PDF: 754
    HTML: 13
1 - 25 of 34 items 1 2 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy